Hypoxia induces histone clipping and H3K4me3 loss in neutrophil progenitors resulting in long-term impairment of neutrophil immunity.
Summary
This mechanistic study shows that systemic hypoxia triggers N-terminal histone H3 clipping in neutrophil progenitors, leading to genome-wide H3K4me3 loss and long-term impairment of neutrophil effector functions months after ARDS. Human data (post-ARDS cohort and hypoxemia-exposed volunteers) and mouse models converge to implicate hypoxia as a causal driver of sustained immune vulnerability.
Key Findings
- Patients 3–6 months post-ARDS exhibited persistently impaired neutrophil effector functions and higher susceptibility to secondary infections.
- Genome-wide loss of activating histone mark H3K4me3 in neutrophil genes was observed, linked mechanistically to N-terminal histone H3 clipping.
- Hypoxemia alone (altitude exposure in volunteers) reproduced long-term neutrophil reprogramming; mouse hypoxia models localized defects to proNeu/preNeu progenitors in bone marrow.
Clinical Implications
Findings suggest monitoring and mitigating post-ARDS hypoxemia may reduce prolonged infection susceptibility; they highlight potential targets (histone clipping pathways) for interventions to restore neutrophil function.
Why It Matters
Reveals a previously unrecognized epigenetic mechanism linking hypoxia to long-term innate immune dysfunction after ARDS, with cross-species evidence.
Limitations
- Exact human sample sizes and effect sizes for infection outcomes are not provided in the abstract.
- Translational interventions to reverse epigenetic changes were not tested.
Future Directions
Define prevalence and duration of hypoxia-induced neutrophil reprogramming in larger ARDS cohorts, and test therapeutic strategies targeting histone clipping or restoring H3K4me3.
Study Information
- Study Type
- Cohort
- Research Domain
- Pathophysiology
- Evidence Level
- V - Preclinical/mechanistic study with supportive human observational data.
- Study Design
- OTHER